Mohr A - Search Results

1

Impact of short- and medium-chain fatty acids on mitochondrial function in severe inflammation.

Hecker M, Sommer N, Voigtmann H, Pak O, Mohr A, Wolf M, Vadász I, Herold S, Weissmann N, Morty RE, Seeger W, Mayer K. Hecker M, et al. Among authors: mohr a. JPEN J Parenter Enteral Nutr. 2014 Jul;38(5):587-94. doi: 10.1177/0148607113489833. Epub 2013 May 23. JPEN J Parenter Enteral Nutr. 2014. PMID: 23703093

2

Immunomodulation by n-3- versus n-6-rich lipid emulsions in murine acute lung injury--role of platelet-activating factor receptor.

Schaefer MB, Ott J, Mohr A, Bi MH, Grosz A, Weissmann N, Ishii S, Grimminger F, Seeger W, Mayer K. Schaefer MB, et al. Among authors: mohr a. Crit Care Med. 2007 Feb;35(2):544-54. doi: 10.1097/01.CCM.0000253811.74112.B6. Crit Care Med. 2007. PMID: 17205023

3

AAV-encoded expression of TRAIL in experimental human colorectal cancer leads to tumor regression.

Mohr A, Henderson G, Dudus L, Herr I, Kuerschner T, Debatin KM, Weiher H, Fisher KJ, Zwacka RM. Mohr A, et al. Gene Ther. 2004 Mar;11(6):534-43. doi: 10.1038/sj.gt.3302154. Gene Ther. 2004. PMID: 14999225

4

Manganese superoxide dismutase induces p53-dependent senescence in colorectal cancer cells.

Behrend L, Mohr A, Dick T, Zwacka RM. Behrend L, et al. Among authors: mohr a. Mol Cell Biol. 2005 Sep;25(17):7758-69. doi: 10.1128/MCB.25.17.7758-7769.2005. Mol Cell Biol. 2005. PMID: 16107721 Free PMC article.

5

Constitutively activated nuclear factor-kappaB, but not induced NF-kappaB, leads to TRAIL resistance by up-regulation of X-linked inhibitor of apoptosis protein in human cancer cells.

Braeuer SJ, Büneker C, Mohr A, Zwacka RM. Braeuer SJ, et al. Among authors: mohr a. Mol Cancer Res. 2006 Oct;4(10):715-28. doi: 10.1158/1541-7786.MCR-05-0231. Mol Cancer Res. 2006. PMID: 17050666

6

TRAIL-induced apoptosis is preferentially mediated via TRAIL receptor 1 in pancreatic carcinoma cells and profoundly enhanced by XIAP inhibitors.

Stadel D, Mohr A, Ref C, MacFarlane M, Zhou S, Humphreys R, Bachem M, Cohen G, Möller P, Zwacka RM, Debatin KM, Fulda S. Stadel D, et al. Among authors: mohr a. Clin Cancer Res. 2010 Dec 1;16(23):5734-49. doi: 10.1158/1078-0432.CCR-10-0985. Epub 2010 Oct 12. Clin Cancer Res. 2010. PMID: 20940278

7

Identification of deficient mitochondrial signaling in apoptosis resistant leukemia cells by flow cytometric analysis of intracellular cytochrome c, caspase-3 and apoptosis.

Stahnke K, Mohr A, Liu J, Meyer LH, Karawajew L, Debatin KM. Stahnke K, et al. Among authors: mohr a. Apoptosis. 2004 Jul;9(4):457-65. doi: 10.1023/B:APPT.0000031454.62937.fa. Apoptosis. 2004. PMID: 15192328

8

MnSOD protects colorectal cancer cells from TRAIL-induced apoptosis by inhibition of Smac/DIABLO release.

Mohr A, Büneker C, Gough RP, Zwacka RM. Mohr A, et al. Oncogene. 2008 Jan 31;27(6):763-74. doi: 10.1038/sj.onc.1210673. Epub 2007 Jul 23. Oncogene. 2008. PMID: 17653087

9

Histone deacetylase inhibitors cooperate with IFN-gamma to restore caspase-8 expression and overcome TRAIL resistance in cancers with silencing of caspase-8.

Häcker S, Dittrich A, Mohr A, Schweitzer T, Rutkowski S, Krauss J, Debatin KM, Fulda S. Häcker S, et al. Among authors: mohr a. Oncogene. 2009 Sep 3;28(35):3097-110. doi: 10.1038/onc.2009.161. Epub 2009 Jul 13. Oncogene. 2009. PMID: 19597472

10

The TRAIL-receptor-1: TRAIL-receptor-3 and -4 ratio is a predictor for TRAIL sensitivity of cancer cells.

Büneker C, Mohr A, Zwacka RM. Büneker C, et al. Among authors: mohr a. Oncol Rep. 2009 May;21(5):1289-95. doi: 10.3892/or_00000353. Oncol Rep. 2009. PMID: 19360306 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

648 results

Search Page

Filters